Daejeon, South Korea

Ji Yong Yoon


 

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Yuseong-gu, KR (2017)
  • Daejeon, KR (2014 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Ji Yong Yoon in Antibody Preparation

Introduction

Ji Yong Yoon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the preparation and purification of antibodies. With a total of four patents to his name, Yoon's work has the potential to impact the development of therapeutic antibodies and biosimilars.

Latest Patents

One of Ji Yong Yoon's latest patents is a method for preparing antibodies through the regulation of sugar content. This innovative method involves culturing antibody-expressing cells in a medium that includes glycerol as an additive. This approach allows for the regulation of the sugar chain content of antibodies, leading to the preparation of a high-quality population of antibodies. Additionally, Yoon has developed a method for antibody purification that enhances the purity and quality of antibodies by removing isoforms and impurities using a series of chromatography columns.

Career Highlights

Throughout his career, Ji Yong Yoon has worked with notable companies such as Prestige Biopharma Pte. Ltd. and Hanwha Chemical Corporation. His experience in these organizations has contributed to his expertise in antibody development and purification techniques.

Collaborations

Ji Yong Yoon has collaborated with several professionals in his field, including Dong Eun Lee and Won Kyum Kim. These collaborations have likely enriched his research and development efforts in antibody technology.

Conclusion

Ji Yong Yoon's innovative methods in antibody preparation and purification demonstrate his significant contributions to biotechnology. His work not only advances the field but also holds promise for the future of therapeutic antibody development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…